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Summary
Background Avahan, the India AIDS initiative of the Bill & Melinda Gates Foundation, was a large-scale, targeted HIV 
prevention intervention. We aimed to assess its overall eﬀ ectiveness by estimating the number and proportion of HIV 
infections averted across Avahan districts, following the causal pathway of the intervention.
Methods We created a mathematical model of HIV transmission in high-risk groups and the general population using 
data from serial cross-sectional surveys (integrated behavioural and biological assessments, IBBAs) within a Bayesian 
framework, which we used to reproduce HIV prevalence trends in female sex workers and their clients, men who have 
sex with men, and the general population in 24 South Indian districts over the ﬁ rst 4 years (2004–07 or 2005–08 
dependent on the district) and the full 10 years (2004–13) of the Avahan programme. We tested whether these 
prevalence trends were more consistent with self-reported increases in consistent condom use after the implementation 
of Avahan or with a counterfactual (assuming consistent condom use increased at slower, pre-Avahan rates) using a 
Bayes factor, which gave a measure of the strength of evidence for the eﬀ ectiveness estimates. Using regression 
analysis, we extrapolated the prevention eﬀ ect in the districts covered by IBBAs to all 69 Avahan districts.
Findings In 13 of 24 IBBA districts, modelling suggested medium to strong evidence for the large self-reported increase 
in consistent condom use since Avahan implementation. In the remaining 11 IBBA districts, the evidence was weaker, 
with consistent condom use generally already high before Avahan began. Roughly 32 700 HIV infections (95% 
credibility interval 17 900–61 600) were averted over the ﬁ rst 4 years of the programme in the IBBA districts with 
moderate to strong evidence. Addition of the districts with weaker evidence increased this total to 62 800 (32 000–118 000) 
averted infections, and extrapolation suggested that 202 000 (98 300–407 000) infections were averted across all 
69 Avahan districts in South India, increasing to 606 000 (290 000–1 193 000) over 10 years. Over the ﬁ rst 4 years of the 
programme 42% of HIV infections were averted, and over 10 years 57% were averted.
Interpretation This is the ﬁ rst assessment of Avahan to account for the causal pathway of the intervention, that of 
changing risk behaviours in female sex workers and high-risk men who have sex with men to avert HIV infections in 
these groups and the general population. The ﬁ ndings suggest that substantial preventive eﬀ ects can be achieved by 
targeted behavioural HIV prevention initiatives.
Funding Bill & Melinda Gates Foundation.
Introduction
In the early 2000s, India was believed to have the highest 
burden of HIV infections in the world,1 with prevalence 
rapidly increasing.2,3 Therefore, in 2003, the Bill & 
Melinda Gates Foundation established Avahan, the India 
AIDS initiative, to target the high-risk groups that the 
evidence suggested were driving the HIV epidemic in 
India.4,5 By reducing the prevalence in these groups, they 
hoped to interrupt the downstream chain of transmission 
to the general population. Avahan established a large-
scale, targeted HIV preventive intervention, providing 
services to an estimated 300 000 female sex workers and 
high-risk men who have sex with men (ie, those who 
have large numbers of partners, often sell sex, or practice 
receptive anal sex).6
Through state-level providers and local non-gov-
ernmental organisations (NGOs), Avahan worked in 
69 districts in four states of South India (Andhra Pradesh, 
Karnataka, Maharashtra, and Tamil Nadu). Programme 
components outside the scope of this assess ment were 
active in other regions, reaching truck drivers and 
injecting drug users. The standard Avahan care package 
consisted of peer education and outreach; distribution 
and social marketing of condoms; treatment of sexually 
transmitted infections (STIs) for female sex workers and 
high-risk men who have sex with men; and structural 
interventions and community mobilisation components 
to address distal determinants of HIV risk such as 
violence and stigma.6 Antiretroviral therapy was not 
oﬀ ered as part of this package, but HIV counselling and 
testing were strongly promoted, with active referral to 
government antiretroviral therapy centres for individuals 
who tested positive. Overall, coverage of antiretroviral 
therapy by government and private clinics reached only 
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37–45% of the estimated need by 2009,7,8 although it has 
since increased.9
Rollout of Avahan programme activities began in 
January, 2004, reaching almost all districts by mid-2005,10 
and with rapid scale-up within each district.11–13 By 
December, 2008, more than 75% of the estimated target 
populations of female sex workers (total population 
217 000) and high-risk men who have sex with men (total 
population 80 000) were being contacted monthly.10 In 
28 districts Avahan was the ﬁ rst and only intervention;10 
in the remaining 41 districts it worked alongside or took 
over from existing NGO interventions. From an assess-
ment standpoint, this rapid rollout, the presence of other 
interventions, and ethical considerations mitigated 
against the use of community-based randomised 
controlled trials or a stepped-wedge study design.14–16
This independent assessment (the CHARME-India 
project) was planned as an integral part of Avahan.17 In 
place of community-based randomised controlled trials, 
we used mathematical modelling with detailed HIV and 
STI prevalence and behavioural data to obtain plausible 
evidence for the eﬀ ectiveness of the intervention.17 We ﬁ rst 
investigated the eﬀ ect of Avahan in the high-risk groups 
targeted by the intervention, and then traced the eﬀ ect on 
their long-term partners in the general population, 
reﬂ ecting the intended causal pathway of the intervention. 
We believe that this approach improves on a previous 
analysis of the population-level eﬀ ect of Avahan,18 which 
did not take into account the high-risk groups on which 
programme activities focused, but instead used a static 
approach to model eﬀ ectiveness through district-level 
diﬀ erences in HIV prevalence trends in women attending 
antenatal care clinics. That analysis was also limited by the 
fact that antenatal clinic data can be subject to transient 
biases,19–21 leading to estimated HIV time trends that are 
unrepresentative of the general population prevalence.22
By means of a Bayesian inference method,23 we aimed 
to use hypothesis testing to examine whether observed 
prevalence trends in high-risk groups were suggestive 
of evidence for condom use increasing faster during 
Avahan than beforehand, and to estimate, using the 
mathematical model, the number and proportion of 
HIV infections averted by Avahan because of these 
increases in condom use (ranked by the strength of 
evidence from the hypothesis testing).
Methods
Data sources
The primary data collected as part of the Avahan 
assessment were the serial cross-sectional integrated 
behavioural and biological assessment (IBBA) surveys 
done among female sex workers, their clients, and men 
who have sex with men in 24 districts, referred to as 
IBBA districts.24,25 IBBA districts have about 38% of the 
female sex workers and 45% of the high-risk men who 
have sex with men across the 69 Avahan districts in 
South India. At least two rounds of IBBAs for female sex 
workers were done in each district, with a median of 
37 months between rounds one and two (appendix).
We used IBBA data to obtain behavioural parameter 
estimates, and HIV and STI prevalence data for model 
ﬁ tting. Additional special behavioural surveys were 
used to reﬁ ne the structure of sexual behaviours in the 
mathematical model (appendix). We also used general 
population biobehavioural surveys from four IBBA 
districts,22,26,27 with concurrent anonymous polling-booth 
behavioural surveys for examining sensitive be-
haviours,28 to derive ranges for behavioural parameters 
of the general population.
Data collection for the IBBAs started 7–24 months after 
intervention activities began, so no true baseline surveys 
or pre-Avahan data for condom use exist. Therefore we 
estimated time trends for consistent condom use before 
Avahan from IBBA data, as reported previously.29 After 
the start of Avahan, consistent condom use was assumed 
to increase up to the proportions reported in each IBBA 
survey, because of scale-up in each district, and to remain 
constant thereafter at the proportion reported in the most 
recent IBBA. We used these estimated historical trends 
in consistent condom use to deﬁ ne the intervention 
condom hypothesis (ie, that consistent condom use 
increased more rapidly during Avahan than before hand), 
used at the hypothesis-testing stage and to estimate 
eﬀ ectiveness. Programmatic outputs, such as number of 
STI clinic visits, were monitored monthly by NGOs from 
January, 2005,10 until April, 2011, and were used to 
estimate syphilis treatment rates (appendix).
Finally, Avahan grantees did mapping exercises to 
estimate the population sizes of female sex workers and 
high-risk men who have sex with men. We used the most 
recent available size estimates for each district. We 
estimated client population sizes indirectly using a 
multiplier method that involved balancing the overall 
frequency of com mercial sex reported by female sex 
workers and their clients (appendix).30,31 Estimates were 
validated with data from general population polling-booth 
surveys28 where available. Table 1 summarises the main 
parameters, a full list of which is reported in the appendix.
Transmission model
A previously reported model of HIV transmission23 was 
extended to simulate the HIV epidemic in high-risk groups 
and between high-risk individuals and their partners in 
IBBA districts. The model has two components: a 
deterministic transmission-dynamics model of HIV, 
herpes simplex virus 2 (HSV2), and syphilis in high-risk 
groups (high-risk model component); and a linked, 
individual-based model of HIV and HSV2 transmission to 
the long-term, non-commercial partners of high-risk men 
and former high-risk individuals (general-population 
model component). The individual-based component was 
chosen to better represent long-term stable relationships.
Both model components incorporated increased 
transmissibility during acute and late-stage HIV infection 
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and the cofactor eﬀ ects of HSV2 on HIV infectivity and 
susceptibility. The high-risk model component also in-
cluded the cofactor eﬀ ect of syphilis on HIV susceptibility. 
The appendix provides a full description of the model.
Fitting and hypothesis testing
The two hypotheses we examined were the intervention 
condom hypothesis, which generally suggests that con-
sistent condom use increased more rapidly during Avahan 
than beforehand; and the control condom hypothesis, 
which was deﬁ ned as consistent condom use increasing at 
the same rate during Avahan as beforehand—ie, that 
Avahan had no additional eﬀ ect on consistent condom use 
beyond what was already happening. A Bayesian model-
ﬁ tting algorithm23,32 was used to test whether each district’s 
observed HIV prevalence trends in high-risk groups were 
more consistent with one hypothesis or the other. For both 
hypotheses, consistent condom use remained stable after 
the ﬁ nal IBBA. The appendix includes the consistent 
condom use trends for each district.
We deﬁ ned ranges for each model parameter for each 
district using data from IBBA and other surveys, as well 
as the scientiﬁ c literature for biological parameters 
(table 1, appendix). We then uniformly sampled these 
ranges multiple times using Latin hypercube sampling,33 
as described in the appendix. For each parameter set thus 
created, the model was run twice for both the intervention 
and control condom hypotheses. Only simulations 
within the 95% CI of prevalence data for HIV, HSV2, and 
syphilis from the round one IBBA for diﬀ erent high-risk 
groups, and within the 95% CI of the adjusted trend in 
HIV prevalence among female sex workers between 
round one and later IBBA rounds, were retained as 
model ﬁ ts to form the posterior parameter set for that 
district for the given condom use hypothesis. For 
hypothesis testing, the Bayes factor, described fully in the 
appendix and approximated by the ratio of the number of 
ﬁ ts to each hypothesis, was used to determine whether 
there was weak (Bayes factor ≤2), moderate (>2 to 5) or 
strong (>5) evidence34 for the intervention condom 
HIV prevalence in 
female sex workers, 
round one IBBA (%)
HIV prevalence 
ratio* in 
female sex 
workers
Consistent 
condom use at 
start of Avahan 
(%)
Consistent condom 
use at ﬁ nal IBBA 
round (%)
Number of clients per 
female sex worker per 
week, round 1 IBBA
Female sex worker 
population size
(n)
Andhra Pradesh
Karimnagar 21·1 0·30 8·3 75·0 8·9 2885
Warangal 10·8 0·39 12·2 76·1 9·4 1982
Vizag 14·2 0·74 15·2 85·1 14·3 1312
Prakasham 11·1 0·79 4·1 95·6 13·1 3226
Chitoor 8·0 1·21 6·6 84·3 11·1 7040
Guntur 21·3 0·67 10·1 82·9 15·5 6380
East Godavari 26·3 0·89 29·9 97·2 12·9 1392
Hyderabad 14·3 0·83 39·5 70·0 6·3 885
Karnataka
Bellary 15·6 0·44 38·8 87·4 11·3 4286
Mysore 26·1 0·58 18·3 91·2 7·8 2278
Shimoga 9·7 0·88 29·9 83·8 6·2 1882
Belgaum 33·9 0·75 48·5 96·6 13·7 2000
Bangalore 12·7 0·86 46·7 85·7 8·2 12 438
Maharashtra
Mumbai 16.2 0·87 72·3 86.1 9·3 10 599
Parbhani 15·9 0·63 56·0 98·1 10·1 1535
Kolhapur 33·0 0·87 80·3 99·5 17·4 833
Yevatmal 37·3 0·58 55·2 98·7 24·4 969
Pune 38·1 0·71 85·9 96·7 13·7 5948
Thane 10·0 1·38 88·1 86·7 11·5 11 889
Tamil Nadu
Dharmapuri 12·4 0·58 9·7 73·7 12·4 2786
Coimbatore 6·3 1·16 3·9 95·9 6·8 2000
Chennai 2·2 0·63 31·1 94·5 6·5 4000
Madurai 4·3 1·55 18·0 99·8 7·2 7887
Salem 12·6 1·05 19.8 94·7 7·5 3353
IBBA=integrated behavioural and biological assessment. *Ratio of ﬁ nal IBBA round to IBBA round one.
Table 1: Mean HIV data used in ﬁ tting and mean prior values for key parameters in the model, by district
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hypothesis compared with the control hypothesis in that 
district. This method is similar to techniques used in 
previous analyses.23,32,35,36
Eﬀ ectiveness analysis
For each modelled district, we obtained between 30 and 
266 ﬁ tted runs for the intervention condom hypothesis, 
capturing the uncertainty from biological and behavioural 
parameters in the model projections. These runs 
generated district-level estimates of HIV prevalence and 
incidence over time, as well as the number of HIV 
infections among high-risk individuals and linked 
infections to long-term partners of present and former 
high-risk individuals. To estimate eﬀ ectiveness in each 
district, we produced a matched counterfactual for each 
model ﬁ t of the intervention condom hypothesis, using 
the same posterior parameter set, but instead assuming 
that consistent condom use increased in accordance with 
the control condom hypothesis and that syphilis 
treatment remained at the assumed background rate. We 
calculated HIV infections averted for each model ﬁ t 
relative to this matched counterfactual, and combined 
these ﬁ ts to give a 95% credibility interval (CrI) for the 
number and proportion of infections averted in each 
district using likelihood weights,23 as described in the 
appendix. Eﬀ ectiveness was calculated over 4 and 10 years 
because these time periods corresponded to the ﬁ rst 
phase of the Avahan programme (2004–07 or 2005–08 
dependent on the district, during which time it reached 
scale10) and entirety of the programme (2004–13), 
respectively. The programme has now largely been 
handed over to the Indian Government.
We estimated infections averted among female sex 
workers; clients of female sex workers; men who have 
sex with men; and long-term, non-commercial partners 
of clients and men who have sex with men. We derived 
ﬁ ve alternative overall eﬀ ectiveness estimates across all 
Avahan districts with increasing uncertainty, repre-
senting the hypothesis-testing results and the fact that 
not all IBBA districts had done surveys among men who 
have sex with men and the general population. Table 2 
and the appendix fully describe these estimates and the 
sources of uncertainty. The ﬁ rst estimate included only 
IBBA districts in which the evidence for the intervention 
condom hypothesis was moderate to strong (ie, Bayes 
factor >2), and estimates of infections averted among 
men who have sex with men and the general population 
were included only for districts with data available for 
these populations. Eﬀ ectiveness among men who have 
sex with men and the general population in districts with 
moderate to strong evidence were added successively to 
produce the subsequent estimates. For the fourth 
estimate, districts with weak evidence (Bayes factor ≤2) 
were included. Finally, because IBBAs were only done in 
about a third of all Avahan districts, we extrapolated our 
estimates to all non-IBBA districts. We used linear 
regression for the estimates of HIV infections averted in 
modelled IBBA districts to extrapolate to non-IBBA 
districts using data, such as the sizes of high-risk 
populations, available across all Avahan districts. This 
estimate produced the overall number of HIV infections 
averted over the ﬁ rst 4 and all 10 years of Avahan in South 
India, but with the highest degree of uncertainty.
Role of the funding source
The sponsor of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had 
full access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication.
Results
Figure 1 provides a summary of the results of the 
hypothesis-testing analysis. Two of the 24 IBBA districts 
Including eﬀ ect in men 
who have sex with men
Including eﬀ ect in general 
population
Which districts included? Median HIV infections averted (95% CrI)
First 4 years 
(2004–07 or 
2005–08)
10 years (2004–13)
13 IBBA districts Only in eight districts 
with IBBAs for men who 
have sex with men
Only in four districts with 
general population surveys
Only IBBA districts with 
medium or strong evidence
32 700 
(17 900–61 600)
105 000 
(53 100–195 000)
13 IBBA districts All 13 districts Only in four districts with 
general population surveys
Only IBBA districts with 
medium or strong evidence
35 300 
(18 800–64 600)
116 000 
(52 500–200 000)
13 IBBA districts All 13 districts All 13 districts Only IBBA districts with 
medium or strong evidence
39 900 
(20 800–76 300)
140 000 
(61 500–246 000)
All 22 IBBA districts All 22 districts All 22 districts All 22 districts 62 800 
(32 000–118 000)
214 000 
(99 000–373 000)
All 69 Avahan districts All districts All districts All districts 202 000 
(98 300–407 000)
606 000* 
(290 000–1 193 000)
CrI=credibility interval. IBBA=integrated behavioural and biological assessment. *The estimate for the number of HIV infections averted over 10 years in all 69 Avahan 
districts has the highest degree of uncertainty.
 Table 2: Estimates of the number of HIV infections averted over the ﬁ rst 4 years and all 10 years of Avahan, with decreasing certainty
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(Salem and Thane) could not be analysed because they 
had no ﬁ ts with either the intervention or the control 
condom hypothesis, due to conﬂ icting trends in HIV 
prevalence data between diﬀ erent risk groups.
Seven of the remaining 22 districts had strong evidence 
(Bayes factor >5) and six had moderate evidence (Bayes 
factor >2 to 5) that consistent condom use by female sex 
workers increased during Avahan. Nine districts had 
weak evidence (Bayes factor ≤2). In districts with weak 
evidence, the overall diﬀ erence in consistent condom use 
between the intervention and control condom hypotheses 
in 2010 was generally smaller (16%) than for districts 
with moderate or strong evidence (57%; p=0·01 [Mann-
Whitney test of the medians]; ﬁ gure 2). This result was 
partly caused by the estimated baseline consistent 
condom use being higher (48%) in the districts with 
weak evidence than in the districts with moderate to 
strong evidence (12%). In four of the ﬁ ve modelled 
districts in which Avahan was the ﬁ rst intervention 
targeted at female sex workers, there was moderate or 
strong evidence for the intervention condom hypothesis; 
the exception was Yevatmal, where there was weak 
evidence, probably because its small IBBA sample size of 
female sex workers resulted in less informative estimates 
of condom use and HIV prevalence.
Figure 1 also shows the overall district-speciﬁ c median 
proportions and numbers of infections averted in all 
population groups (including the general population) over 
the ﬁ rst 4 years of Avahan. New HIV infections decreased 
sub stantially in most IBBA districts, with 42% 
(95% CrI 33–51) of infections averted across the modelled 
districts. Generally, a larger proportion of infections was 
averted in districts with moderate to strong evidence than 
in those with weak evidence (median 51% vs 30%). 
Intervention eﬀ ectiveness varied across states, largely 
because of diﬀ erences in baseline consistent condom use, 
Andhra Pradesh
Karimnagar
Warangal
Vizag
Prakasham
Chitoor
Guntur
East Godavari
Hyderabad
Karnataka
Bellary
Mysore
Shimoga
Belgaum
Bangalore
Maharashtra
Mumbai
Parbhani
Kolhapur
Yevatmal
Pune
Tamil Nadu
Dharmapuri
Coimbatore
Chennai
Madurai
State-level estimates
Andhra Pradesh
Karnataka
Maharashtra
Tamil Nadu
Overall estimate (all modelled districts)
 >10*
 6·6
 6·1
 5·7
 4·4
 4·1
 1·4
 −6·8
 7·2
 2·5
 2·3
 –2·3
 −0·6
 5·9
 1·6
 −0·9
 −1·4
 −2·4
 >10*
 3·6
 2·1
 −2·7
Bayes factor
4459
1545
1446
1647
6060
8046
1675
55
3919
1651
839
2015
5055
1459
837
215
1268
367
4719
2321
1766
11 434
Number averted
0 10 20 30 40
Proportion of HIV infections averted (%)
50 60 70 80
Figure 1: Proportions and total numbers of HIV infections averted over ﬁ rst 4 years of Avahan in each modelled IBBA district, including estimates from men 
who have sex with men and the general population
The Bayes factor describes the strength of evidence for the eﬀ ectiveness estimate in each district (strong evidence=Bayes factor >5; moderate evidence=Bayes 
factor >2 to 5; and weak evidence=Bayes factor ≤2). IBBA=integrated behavioural and biological assessment. *No ﬁ ts to the control condom hypothesis.
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with 67% of infections averted in Tamil Nadu, 49% in 
Andhra Pradesh, 36% in Karnataka, and 12% in 
Maharashtra. Over 10 years, eﬀ ectiveness increased in all 
districts, with 57% (46–68%) of HIV infections averted 
across the modelled districts.
The median number of HIV infections averted per 
district over the ﬁ rst 4 years of the programme varied from 
55 to more than 11 400. Six districts (four with moderate to 
strong evidence) contributed 63% of all infections averted, 
whereas the bottom six by contribution (ﬁ ve with weak 
evidence) contributed only 6%. The total number of 
infections averted each year increased from 5000 in year 1 
to 14 000 in year 2, 20 000 in year 3, and 23 800 in year 4. 
Over the ﬁ rst 4 years, most HIV infections were averted 
among clients of female sex workers (51% of all infections 
averted), who formed the largest high-risk subpopulation, 
followed by the general population (19%), men who have 
sex with men (17%), and female sex workers (13%).
The district-speciﬁ c estimates of eﬀ ectiveness (ﬁ gure 1) 
include infections averted in all population subgroups 
over the ﬁ rst 4 years, even for districts without surveys of 
men who have sex with men and the general population, 
and the state-level and overall proportion of infections 
averted across all modelled districts. Table 2 shows the 
overall infections averted over 4 and 10 years, by 
increasing degree of uncertainty.
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Figure 2: Trends in consistent condom use and HIV prevalence among female sex workers
(A) Consistent condom use in districts with moderate to strong evidence. (B) HIV prevalence in districts with moderate to strong evidence. (C) Consistent condom 
use in districts with weak evidence. (D) HIV prevalence in districts with weak evidence. District-level estimates were weighted by the relative population size of female 
sex workers. Data are median values, with dark shaded areas representing 50% credibility intervals (CrIs) and light shaded areas representing 95% CrIs.
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In 18 IBBA districts, the modelled HIV prevalence 
among female sex workers fell during the ﬁ rst 4 years 
under the intervention condom hypothesis by 11% to 
52% dependent on the district, whereas it increased in 
four districts. Over 10 years, the projected median HIV 
prevalence fell in all districts to less than 14% among 
female sex workers, with only six districts having a 
median prevalence higher than 5% in this subpopulation 
(district-level prevalence-trend graphs are provided in the 
appendix). By comparison, under the control condom 
hypothesis HIV prevalence among female sex workers 
remained high, with seven districts having a prevalence 
higher than 20% after 10 years. Figure 2 shows the mean 
prevalence trends weighted by the size of the female sex 
worker population, grouped by strength of evidence. 
After the ﬁ rst 4 years, the HIV incidence ratio between 
the intervention and matched counterfactual varied by 
between 0·08 and 0·92 (median 0·30) across modelled 
districts. For the intervention condom hypothesis, 
incidence in low-risk women fell during the ﬁ rst 4 years 
in 19 districts, and after 10 years it had fallen by at least 
70% in all districts, with larger reductions in incidence 
among female sex workers (appendix).
When only the subset of variables available across all 
Avahan districts was used, 62% of the variability in the 
number of HIV infections averted over the ﬁ rst 4 years 
across IBBA districts, as measured by the R² value of 
the linear regression model, was accounted for by: the 
number of female sex workers in a district (positively 
associated, accounted for 24% of the variability); 
whether Avahan was the main intervention provider for 
female sex workers in the ﬁ rst year in that district 
(positively associated, 26%); and being a district in 
Maharashtra state (negatively associated, 12%). When 
this regression model, described in the appendix, was 
used to ex trapolate eﬀ ectiveness estimates to all non-
IBBA districts, the overall eﬀ ectiveness of Avahan for 
all 69 districts was estimated to be 202 000 HIV 
infections averted over the ﬁ rst 4 years (table 2), with 
37% of infections averted in Andhra Pradesh, 30% in 
Karnataka, 8% in Maharashtra, and 25% in Tamil Nadu. 
Over 10 years, the number of infections averted 
increased to 606 000 across all districts. The two 
regression models for eﬀ ectiveness over 4 and 10 years 
had the same independent variables, although they 
were built independently. Figure 3 shows how the 
number of infections averted varied geo graphically 
across all Avahan districts.
Discussion
Our results provide evidence for a large-scale increase in 
consistent condom use in high-risk groups since the start 
of the Avahan programme. Hypothesis-testing results 
show HIV prevalence trends are consistent with self-
reported trends in consistent condom use by female sex 
workers and men who have sex with men in most 
districts, and that consistent condom use increased faster 
after the introduction of Avahan than before. Across the 
22 modelled districts, the increases in consistent condom 
use that occurred during the ﬁ rst 4 years of Avahan are 
State capital
Not Avahan
<2000
2000–4000
4000–6000
>6000
A B
Figure 3: Distribution of the number of HIV infections averted over ﬁ rst 4 years (A) and all 10 years (B) across all Avahan districts in southern India
Districts that were not modelled are shaded with diagonal stripes.
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estimated to have averted 42% of HIV infections, 
increasing to 57% over 10 years of the programme. This 
increase translates to 32 700–39 900 HIV infections 
averted over the ﬁ rst 4 years in districts with moderate to 
strong evidence, or 62 800 across all modelled districts. 
Extrapolating to all 69 Avahan districts, we estimate that 
202 000 HIV infections could have been averted over the 
ﬁ rst 4 years of Avahan, increasing to 606 000 over 10 years. 
Both prevalence and incidence fell steeply in most 
districts, across all risk groups.
For districts in which hypothesis testing did not show 
evidence of increased consistent condom use due to 
Avahan, this ﬁ nding was probably because consistent 
condom use was generally quite high before Avahan 
(ﬁ gure 2). Our attribution of eﬀ ectiveness to Avahan is 
supported by other analyses. First, research by Bradley 
and colleagues37 showed that condom distribution 
increased substantially in Karnataka after 2004, mainly 
because of Avahan, and suggested that the proportion of 
sex acts between female sex workers and their clients 
that were protected by a condom increased from 16–24% 
in 2004 to 81–89% in 2008. Second, statistical analysis of 
the reconstructed trend data for consistent condom use 
by female sex workers suggests that use increased faster 
after the beginning of Avahan than before in ten of 
18 districts.29 Finally, survey data suggest a dose-response 
relation between condom use between female sex 
workers and their clients and both time since ﬁ rst contact 
with Avahan staﬀ  and the number of condom 
demonstrations seen.38
The eﬀ ectiveness of the intervention varied across 
districts, with the proportion of infections averted 
inversely related to pre-intervention consistent condom 
use (appendix). Understandably, for districts in which 
previous interventions had already led to high consistent 
condom use among high-risk groups before Avahan, 
only small, incremental eﬀ ects could be achieved. 
Districts with low HIV prevalence and low consistent 
condom use at baseline, such as those in Tamil Nadu, 
had more infections averted than other districts, because 
the epidemic had more potential to grow.
Our results diﬀ er in several important ways from those 
of the previous assessment of Avahan by Ng and 
colleagues,18 which estimated that 100 200 HIV infections 
were averted by Avahan between 2004 and 2008. The 
earlier analysis compared HIV prevalence trends in 
women attending antenatal care clinics between Avahan 
and non-Avahan districts, with the assumption that 
intervention coverage was higher in Avahan districts. By 
contrast, our method compared the HIV epidemic trends 
in each district with what might have occurred in the 
absence of Avahan or any other intense, core-group 
intervention. Ng and colleagues’ analysis probably 
underestimated the eﬀ ectiveness of Avahan, since the 
Indian Government, through the National AIDS Control 
Organisation (NACO), implemented high-coverage, 
targeted interventions in many non-Avahan districts,9 so 
non-Avahan districts have been exposed to interventions 
and cannot always be used as a valid counterfactual.
For example, in Tamil Nadu, Ng and colleagues18 
reported no evidence for the eﬀ ectiveness of Avahan, 
probably because of the long history of interventions in 
many of the non-Avahan districts in that state. By contrast, 
because Avahan was usually the ﬁ rst and only intervention 
in the districts of Tamil Nadu in which it operated, our 
analysis estimated that 25% of HIV infections averted 
across all Avahan districts were in that state. Although 
Banandur and colleagues39 used a similar method to Ng 
and colleagues,18 their estimate of 87 000 HIV infections 
averted in Karnataka state between 2004 and 2008 is fairly 
close to our estimate of 60 300 over 4 years (data not 
shown).
The two approaches to the assessment of Avahan diﬀ er 
in other ways. The previous analyses took into account 
only the eventual eﬀ ect on the general population, 
without investigating the causal pathway through which 
the intervention achieved its eﬀ ects.16 By contrast, our 
analysis ﬁ rst assessed eﬀ ectiveness in the high-risk 
groups that were the focus of the Avahan programme, 
and then projected how this eﬀ ect propagated to the 
general population, thereby taking into account the 
targeted nature of the intervention. It thus addresses 
some of the issues related to causation (panel).
Assessment of the eﬀ ectiveness of HIV preventive 
interventions is crucial for determining which strategies 
should be prioritised.46 This study sought to determine 
whether there is evidence that Avahan reduced the 
transmission of HIV among high-risk groups and the 
general population. It represents the ﬁ rst preplanned, 
integrated use of mathematical modelling and data 
collection for assessment of a real-life, large-scale HIV 
intervention programme,17 and its success suggests that 
our assessment design could be a viable alternative to 
randomised controlled trials.40,43
The mathematical model used was developed 
speciﬁ cally to assess Avahan, with a structure reﬂ ecting 
important sources of heterogeneity in IBBA data. The 
model was reﬁ ned in consultation with epidemiologists 
and other expert non-modellers, and through exploratory 
modelling work.4,20,23 The IBBA surveys used a detailed 
sampling frame derived from careful mapping of venues, 
and were designed for this assessment, providing 
previously unavailable information on HIV prevalence 
and risk behaviour of high-risk individuals across a large 
number of districts. Combined with systematically 
gathered programme data and size-mapping estimates, 
these survey data allowed for detailed and robust 
mathematical modelling projections of the eﬀ ectiveness 
of Avahan in many diﬀ erent settings, while accounting 
for uncertainty in estimates. We used an assessment 
design established17 at the beginning of the study to 
minimise assessor biases. The eﬀ ectiveness estimates 
were deliberately chosen to be conservative, with the 
assumption of the counterfactual scenario that condom 
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use would have continued increasing at pre-Avahan rates 
in the absence of Avahan. Although the results for all 
69 districts are based on an extrapolation from a linear 
regression model of IBBA districts, and therefore have 
more uncertainty, we present results with diﬀ erent 
degrees of strength of evidence to quantify how uncertain 
our results are.
The approach used, of estimating eﬀ ectiveness relative 
to a matched counterfactual, can be regarded as an 
attempt to reach the ideal estimation of relative risk, 
namely the comparison of a population to itself with the 
exposure removed.47 However, it is not possible to know 
exactly what would have happened if Avahan had not 
intervened, and the absence of true empirical baseline 
data increases uncertainty. In some districts pre-existing 
interventions were present, which might have led to 
increased condom use in the absence of Avahan. 
Although our conservative counterfactual makes 
allowances for this, the absence of data from districts 
without any Avahan intervention makes the attribution 
of eﬀ ectiveness to the programme with absolute 
certainty diﬃ  cult. Additionally, limitations arise from 
the use of reconstructed condom trends based on self-
reported condom use, and although we tried to allow for 
social desirability biases within the modelling, as well as 
cross-validating with non-survey methods,37 it is not 
possible to know if this issue has been fully accounted 
for, although the use of Bayesian hypothesis testing 
provides further evidence that these trends are credible 
in these settings.
Eﬀ ectiveness estimates are dependent on the sizes of 
the high-risk populations, and although mapping studies 
were speciﬁ cally done in Avahan districts, the accurate 
mapping of hidden populations is challenging.48 Mi-
gration from non-Avahan districts could reduce estimated 
eﬀ ectiveness. Antiretroviral therapy could also be 
changing the epidemic, leading to higher HIV prevalence 
as survival improves. However, although long-term 
projections could be aﬀ ected by increasing access to 
antiretroviral therapy, coverage remained low until after 
2008, by which time IBBA surveys in most districts had 
been completed.49 More over, modelling work suggests 
that the increase in HIV infections averted by 
antiretroviral therapy on top of the eﬀ ect of Avahan is 
small (unpublished). Finally, although the IBBA districts 
comprise almost a third of all Avahan districts, they were 
not chosen randomly, so might not be representative.50
However, these data limitations, such as the absence of 
baseline data, are neither intrinsic nor unique to our 
approach, and reﬂ ect the realities of programme imple-
mentation and real-life assessment.15 Our use of a 
simulated matched counterfactual for each district 
means that non-random district selection is less prob-
lematic than for approaches in which Avahan and non-
Avahan districts are compared, such as in the study by 
Ng and colleagues,18 or community-based randomised 
controlled trials, for which it might not be possible to 
ﬁ nd comparable control districts, leading to imbalance.51 
A further issue for these alternative assessment designs, 
which rely on non-Avahan control districts, is the scaling-
up of targeted interventions by NACO in non-Avahan 
districts since 2007,9 meaning that such analyses are 
eﬀ ectively comparing Avahan with NACO interventions. 
Finally, although a step-wedge design can be useful for 
assessing intermediate outcomes, the present combined 
approach might be more suitable for assessing HIV 
interventions in populations, since changes in HIV 
prevalence and incidence might not be measurable for a 
long time.51
In summary, using mathematical modelling to quan-
titatively synthesise HIV and STI prevalence data with 
key setting-speciﬁ c behavioural indicators, we have 
shown strong and plausible evidence for a large 
Panel: Research in context
Systematic review
Avahan was a large-scale, complex HIV preventive intervention. Uniquely for such a large 
programme, assessment was based on a preplanned combination of serial cross-sectional 
data and mathematical modelling.17 The use of mathematical modelling for assessment of 
health programmes was reviewed by Garnett and colleagues,40 with the present assessment 
used as an example. Some eﬀ ectiveness assessments of interventions targeted at female 
sex workers were done before Avahan,41,42 including one study42 that examined the eﬀ ect on 
the general population. In 2011, Ng and colleagues18 reported an assessment of Avahan in 
which they compared trends in HIV prevalence in women attending antenatal care clinics 
between Avahan and non-Avahan districts within the same Indian states. They used level of 
intervention eﬀ ort measured in terms of programme spending to take into account the fact 
that, in many districts, a mix of Avahan and non-Avahan interventions were targeting the 
same high-risk populations. The investigators estimated that from 2004 to 2008, Avahan 
had averted about 100 000 HIV cases. Their approach, however, did not take into account 
the causal pathway that could have led to a reduced HIV incidence.16 Using a similar 
method, Banandur and colleagues39 estimated that 87 000 HIV infections were averted by 
Avahan in Karnataka state alone over the same period.
Interpretation
Our study constitutes probably the most rigorous use of mathematical modelling for the 
assessment of a public health programme so far reported. We show that this approach is 
feasible and provides an alternative to community-based randomised controlled trials, 
which might not be the ideal approach to assess large, complex interventions.43 In 
particular, a randomised trial would not have allowed for the context-speciﬁ c, 
community-led response that was an integral part of Avahan.44 Model projections of HIV 
prevalence were ﬁ tted to multiple rounds of data from diﬀ erent risk groups, and a 
Bayesian framework was used to assess the strength of evidence for eﬀ ectiveness. 
Additionally, we explicitly modelled the causal pathway of the intervention. Our study 
also incorporated diﬀ erent degrees of uncertainty dependent on the amount of data 
available for each district. Our results generally support those of Ng and colleagues,18 
showing that Avahan has prevented a large number of HIV cases in India. However, our 
estimate of 202 000 HIV cases averted over the ﬁ rst 4 years of the programme is about 
double that estimated by Ng and colleagues.18 This diﬀ erence was probably due to the 
diﬀ erences in the methods used. Whereas the previous assessment compared Avahan 
with other interventions, our assessment used a modelled counterfactual, in which 
exposure to Avahan was removed from the intervention population. Our assessment 
meets the criteria for plausibility in the Habicht and colleagues’ framework,45 and can be 
replicated for assessment of other large-scale, complex interventions.
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intervention eﬀ ect of Avahan, which increased over time, 
based on Habicht and colleagues’45 scale for assessing the 
strength of evidence for eﬀ ectiveness of public health 
interventions. This eﬀ ect occurred through increased 
condom use, brought about by removing barriers to use 
via intervention components including distribution and 
social marketing of condoms, peer outreach, STI 
treatment, structural intervention, and community 
mobilisation. In an era focused on antiretroviral therapy 
as prevention, these results show that behaviour-focused, 
core-group-targeted HIV preventive interventions can be 
rapidly and successfully implemented at scale. The low 
coverage of such programmes in many regions of the 
world should be addressed, since with high coverage 
these programmes have the potential to substantially 
reduce concentrated HIV epidemics.52,53
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